Bluefin Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bluefin Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-94,904	Closed	-$3.73M	–	243
2023 Q2	$3.73M	Buy	+94,904	New	+$3.35M	0.71%	23
2022 Q4	–	Sell	-118,262	Closed	-$2.12M	–	695
2022 Q3	$2.12M	Buy	+118,262	New	+$1.55M	0.19%	86

Bluefin Capital Management's ISEE Position: Q3 2023 in Review

Bluefin Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 94,904 shares — an estimated $3.73M sold.

Bluefin Capital Management first reported a position in ISEE in Q3 2022 and held it in 2 quarters. The position peaked at $3.73M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Bluefin Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bluefin Capital Management sold 94,904 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.73M.
Bluefin Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Bluefin Capital Management's IVERIC bio, Inc. Common Stock position peaked at $3.73M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Bluefin Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.